We review clinical strategy, surgical workflows, product–clinician fit, and adoption barriers for ophthalmic technologies. This includes cataract platforms, MIGS, interventions, diagnostics, and clinic operations. Success in ophthalmology depends on aligning technology with real clinical practice. We bring current surgical and clinic experience to help you anticipate how products will be used, where they may fail, and how to position them. We provide targeted reviews, structured feedback, and implementation roadmaps tailored to your stage of development, from early concept to post-launch refinement.

We evaluate gene and cell therapy programs with an eye toward biological plausibility, clinical translation, and real-world implementation. Advanced therapies move quickly and are capital-intensive. Teams need rigorous but practical input that connects molecular strategy to patient-level outcomes. We assist with scientific due diligence, translational design questions, high-level protocol review, and positioning within competitive and regulatory landscapes.

We help teams sharpen research questions, design clinically meaningful endpoints, and communicate findings clearly to academic, clinical, or investor audiences. Strong projects can be undermined by unclear framing or weak communication. We provide input on study framing, manuscript and presentation structure, and messaging that accurately represents the data while speaking to the right stakeholders.

We work with applicants to medical school and residency on strategy, timelines, personal statements, and interview preparation. The application process rewards clarity, coherence, and self-awareness. Small mistakes can have outsized effects. We offer structured sessions focused on building a clear narrative, aligning experiences with goals, and preparing for high-stakes conversations.